[Agranulocytosis in oranil therapy].
D000380:Agranulocytosis / Q000209:etiology*; D002271:Carbutamide; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*
D007004:Hypoglycemic Agents; D002271:Carbutamide
AGRANULOCYTOSIS/etiology and pathogenesis; ANTIDIABETICS/injurious effects
Agranulozytose unter Oranilbehandlung.